Mueller T C, Kowalski A, Lefèvre J P. "Method for the Synthesis of Doxorubicin Impurity 16" [P]. European Patent, EP 3844297 A1, 2017-06-13.
Yamamoto T, Hughes D C, Fischer A B. "A Process for Preparing High-Purity Doxorubicin Impurity 16" [P]. US Patent, US 11087556 B2, 2020-05-08.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 多柔比星杂质16 in Pharmaceutical Formulations". J. Sep. Sci., 2011, 1091, 1865-1879.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多柔比星杂质16 as an Impurity". Anal. Methods, 2020, 761, (5), 3643-3651.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Doxorubicin Impurity 16 Using HRMS and NMR". Biomed. Chromatogr., 2015, 756, (7), 3936-3952.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 多柔比星杂质16 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2022, 2093, (7), 8053-8077.